Topic: Cancer Treatment and Research
A summary of mainstream reporting, plus the facts and perspectives it leaves out. A more honest account of each story.
📔 Topics / Cancer Treatment and Research

Cancer Treatment and Research

1 Story
3 Related Topics
FDA Expedites Approval Of First RAS-Targeting Drug For Pancreatic Cancer
The FDA approved daraxonrasib, a drug that targets RAS proteins for pancreatic cancer, on Wednesday, August 26, 2026 in the United States. CBS News